Clinical Trial

Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women

Study acronym: PRP-EpiHeal
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study looks at whether a treatment made from a patient's own blood, called platelet-rich plasma (PRP), can help heal the cut made during childbirth (episiotomy) better than standard care alone. PRP is prepared by drawing a small blood sample from the patient and spinning it in a centrifuge to concentrate the platelets, which contain natural healing factors. In this study, women who have an episiotomy during vaginal delivery will be randomly assigned to one of two groups: one group will receive a single injection of their own PRP at the wound site right after delivery, and the other group will receive the usual standard wound care. Neither group's care will otherwise differ. Researchers will follow each woman for 6 weeks after delivery, checking how well the wound is healing using a standard scoring tool (REEDA score), along with pain levels, any complications like infection or wound reopening, and how satisfied participants are with their recovery. The goal is to find out whether this simple, low-risk treatment using a woman's own blood can speed up healing and reduce discomfort after childbirth.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-21.
Trial Details
NCT Number NCT07669285
Lead Sponsor Saint Andrew Hospital Constanta
Conditions Episiotomy, Platelet Rich Plasma (PRP), Wound Healing, Obstetric
Enrollment 200 participants
Start Date 2026-06-21
Primary Completion 2026-06-21 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-30